A better understanding of SLE pathogenic mechanisms is well mirrored by some proposed synthetic drugs, such as tacrolimus, or biologics, including IFN-α inhibitors and other drugs capable of modulating the immune system. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.